Abstract. The hepatic cytochrome P-450 (CYP) enzyme system provides a major aspect of liver function, yet alterations of CYP in sepsis remain largely unknown. Although we have recently shown that CYP1A2, one of the major isoforms of CYP in rats, is downregulated in sepsis, the underlying mechanism and possible therapeutic approaches warrant further investigation. The aim of this study was to determine whether Kupffer cells (KCs) play any role in suppressing CYP1A2 in the hepatocytes (HCs) and if so, how to modulate CYP1A2 expression in sepsis. To study this, primary KCs and HCs were cultured separately or together with or without transwells. Cells and supernatant samples were collected after various stimulations. Additionally, polymicrobial sepsis was induced in rats by cecal ligation and puncture (CLP) with or without curcumin pre-treatment. Liver samples were harvested 20 h post-CLP. The results show that lipopolysaccharide (LPS) did not suppress CYP1A2 in HC or HC/KC coculture with transwells. However, LPS downregulated CYP1A2, aryl hydrocarbon receptor (AhR, a nuclear receptor) and AhR nuclear translocator (Arnt) in coculture without transwells. Anti-TNF-· and anti-IL-1ß antibodies attenuated this downregulation. Moreover, elevated hepatic levels of TNF-· and IL-1ß post-CLP were decreased by curcumin pretreatment. This reduction was associated with increased expression of AhR and CYP1A2. These results indicate that KCs-derived proinflammatory cytokines may play an important role in downregulating CYP1A2 in sepsis. The reduction of AhR/Arnt may be the underlying mechanism for such downregulation. Inhibition of proinflammatory cytokines by curcumin may provide a novel approach to modulate the hepatic CYP function in sepsis.
Introduction
Sepsis is the leading cause of death in non-cardiac intensive care units with >210,000 people succumbing to overwhelming infection (or the resultant multiple organ failure) in the US annually (1) . Although experimental studies using cell and animal models have greatly improved our understanding of the pathophysiology of sepsis, there remains a remarkable paucity of information regarding the regulation of metabolism of pharmaceutical agents in this important public health problem. In particular, there is a need for better understanding the regulation of cytochrome P-450 (CYP) enzyme system under such conditions.
The hepatic CYP enzyme system constitutes one of the major aspects of hepatocyte function. Our recent studies have shown that one of the major hepatic P-450 isoforms in the rat, CYP1A2, is downregulated in sepsis (2) . CYP1A2 is involved in the metabolism of various exogenous agents such as theophylline, imipramine, and naproxen and can be inhibited by chemicals such as cimetidine and fluoroquinolones (3). It is a major determinant of lidocaine metabolism, a commonly used hepatic CYP function measure (4) . Inhibition of total CYPs produces exacerbated inflammatory responses and potentiated mortality in sepsis (2) . The regulation of CYP by proinflammatory cytokines has been investigated (5,6) However, the mechanism responsible for suppression of hepatic CYP1A2 in sepsis and possible therapeutic approaches to modulate CYP function under such conditions warrants further study.
Curcumin [1,7- bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione], a polyphenol derived from the plant Curcuma longa and commonly called turmeric, has been used for hundreds of years as a safe anti-inflammatory agent in a variety of ailments as part of Indian traditional medicine. However, it is only within the past few years that the activity of curcumin against various diseases has been scientifically documented. Recent studies have shown that curcumin inhibits endotoxin-induced production of TNF-· and IL-1ß from macrophages (7) (8) (9) . In a rat model of endotoxemia, curcumin has been shown to prevent the rapid transcription suppression
Suppression of hepatocyte CYP1A2 expression by
Kupffer cells via AhR pathway: The central role of proinflammatory cytokines of hepatic CYP isoforms (10) . However, whether curcumin has a similar effect in a clinical relevant model of polymicrobial sepsis remained unknown. Transcriptional activation of CYPs involves the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor as well as its nuclear translocator (Arnt) and a chaperone protein heat shock protein 90 (HSP90) (11) (12) (13) . Using a Kupffer cell-hepatocyte coculture system and a rat model of polymicrobial sepsis, the present study was conducted to test the hypothesis that reduction in nuclear receptor AhR, due to the increased production of KC-derived cytokines plays an important role in suppressing hepatic CYP1A2 expression in sepsis; and that inhibition of proinflammatory cytokines by curcumin provides a novel therapeutic approach for the modulation of the hepatic CYP enzyme system under such conditions.
Materials and methods
Cell cultures. Rat KCs were isolated from 6-to 8-week-old normal male Sprague-Dawley rats by collagenase perfusion of the liver, isopycnic sedimentation in a Percoll gradient, and selective adherence (14) . The viability of KCs was >95% and the purity of KCs was >85%. Hepatocytes (HCs) were isolated from normal rats by collagenase perfusion and purified to >95% purity by repeated centrifugation at 50 x g followed by further purification over 50% Percoll (15) . The viability of HCs was >90%. HCs were cultured at a density of 1x10 6 cells/ well in 24-well cell culture plates using Williams medium E containing 10% heat-inactivated bovine serum, supplemented with 15 mM HEPES (pH 7.4), 2 mM L-glutamine, 100 units/ ml penicillin, and 100 μg/ml streptomycin and placed in an incubator at 37˚C in 5% CO 2 /95% air. KCs were cultured in the same medium at a density of 1x10 6 cells/well in 24-well cell culture plates. The HC and KC coculture without transwells (HC+KC) consisted of 0.5x10 6 , attached KCs in 24-well cell culture plates with the addition of 0.5x10 6 HCs in direct contact. In order to eliminate the effect of direct cell to cell contact, a high pore density transwell membrane (0.4 μm; Becton Dickinson Labware, Franklin Lakes, NJ) was used to separate HCs from KCs (allowing proteins to pass through). Briefly, the HC and KC cocultures with transwells (HC+KC/ Membrane) were prepared by culturing 0.5x10 6 KCs at the bottom of 24-well cell culture plates and 0.5x10 6 HCs plated on membrane inserts with a pore size of 0.4 μm. After a recovery period of 24 h, medium was replaced by fresh medium with or without LPS (100 ng/ml) or TNF-· (0.02-2 ng/ ml), IL-1ß (0.02-2 ng/ml) in all culture types. 
Determination of CYP1A2, AhR and Arnt proteins.
The protein expression of CYP1A2, AhR and Arnt was measured by Western blotting. Briefly, 25 μg proteins were fractionated on 4-12% Bis-Tris gel and transferred to 0.2 μm-nitrocellulose membrane. Nitrocellulose blots were blocked by incubation in TBST (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween-20) containing 5% milk for 1 h. Blots were incubated with goat anti-rat CYP1A2 serum (1:600; Daiichi Pure Chemicals, Tokyo, Japan), rabbit anti-rat AhR polyclonal antibody (1:600; BioMol Research Laboratories Inc., Plymouth Meeting, PA) and goat anti-rat Arnt polyclonal antibody (1:150; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) overnight at 4˚C, respectively. The blots were then washed in TBST for 5x10 min. Blots were incubated with HRP labeled anti-goat (1:4000) or anti-rabbit (1:10000) IgG for 1 h at room temperature. The blots were then washed in TBST for 5x10 min. A chemiluminescent peroxidase substrate (ECL, Amersham Biosciences, Inc.) was applied according to the manufacturer's instructions, and the membranes were exposed briefly to X-ray film. The band densities were normalized by actin using the Bio-Rad image system.
Determination of TNF-· and IL-1ß
. TNF-· and IL-1ß levels in the supernatant were quantified using enzyme-linked immunosorbent assay (ELISA) kits, specifically for rat TNF-· and IL-1ß (BioSource International, Camarillo, CA). The assay was carried out according to the instructions provided by the manufacturer.
Neutralization of TNF-· and IL-1ß bioactivity.
In order to determine the effect of TNF-· and IL-1ß in the expression of CYP1A2, both anti-TNF-· and anti-IL-1ß antibodies (10 μg/ ml and 1 μg/ml, respectively; R&D Systems Inc., Minneapolis, MN) were used in the coculture system (KC+HC group only).
Animal model of sepsis. Male Sprague-Dawley rats (275-325 g) were housed in a temperature-controlled room on a 12-h light/ dark cycle and fed a standard Purina rat chow diet. Prior to the induction of sepsis, rats were fasted overnight but allowed water ad libitum. Rats were anesthetized with isoflurane inhalation, and the ventral neck, abdomen and groin were shaved and washed with 10% povidone iodine. Cecal ligation and puncture (CLP) was performed as we previously described (16) and the animals were randomly assigned to various groups. All experiments were performed in accordance with the NIH guidelines for the use of experimental animals. This project was approved by the Institutional Animal Care and Use Committee of the Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System. Administration of curcumin. Curcumin (Sigma Chemical, St. Louis, MO) was dissolved in 50% DMSO:50% DMEM to a final concentration of 1 mM. Mini-pumps (2 ml) (Alzet, 10 μl/h for 7 days) were primed with curcumin solution or vehicle (50% DMSO:50% DMEM) overnight prior to implantation. After a bolus intravenous injection of 0.2-μmol curcumin or 200-μl vehicle, the mini-pumps were connected to a jugular vein catheter and then implanted subcutaneously. Three days after the implantation, rats were subjected to sepsis by CLP. Twenty hours after CLP (i.e., the late, hypodynamic phase of sepsis), the animals were sacrificed and liver samples were collected. The total dosage of curcumin given to each animal in this experiment was 4 μmol/kg BW. The gene expression and protein levels of CYP1A2 and AhR in the liver were determined by RT-PCR and Western blots, respectively. Hepatic levels of TNF-· and IL-1ß were measured by ELISA.
Statistical analysis. All data are expressed as means ± SE and compared by Student's t-test or one-way analysis of variance (ANOVA) and Tukey's test. Differences in values were considered significant at P<0.05. Fig. 1A , LPS did not affect CYP1A2 mRNA expression in HCs. When HCs and KCs were cocultured with direct contact (i.e., KC+HC group), however, CYP1A2 mRNA expression decreased by 32% (P<0.05, Fig. 1A ). Since CYP1A2 expression is significantly higher in HCs than in KCs (data not shown), the decreased CYP1A2 detected in the coculture system was primarily due to the decreased expression of CYP1A2 in HCs. When a high pore density transwell membrane (0.4-μm) was used to separate HCs from KCs (allowing proteins to pass through), the decreased CYP1A2 mRNA expression was prevented ( Fig. 1A ; KC+HC/Membrane group). Similar results were also observed in AhR and Arnt mRNA expression (Fig. 1B-C) , but HSP90 gene expression was not significantly altered under such in vitro conditions (Fig. 1D) . The protein expression of CYP1A2 (58 kDa), AhR (95 kDa) and Arnt (90 kDa) was also significantly reduced in KC+HC group (AhR was also reduced in KC+HC/Membrane group; Fig. 2A-C) . Since the gene expression of HSP90 was not altered in all groups, its protein expression was not measured. To determine whether the downregulated CYP1A2, AhR and Arnt are related with greater cytokine release, TNF-· and IL-1ß levels in the supernatant were measured. As indicated in Fig. 3A and B, coculture with the direct cell contact (KC+HC group) produced the highest TNF-· and IL-1ß levels (IL-1ß was less impressive compared to TNF-·), suggesting that TNF-· in association with IL-1ß may play a role in downregulating CYP1A2 expression after LPS stimulation. To confirm this, both anti-TNF-· and anti-IL-1ß antibodies were used in the coculture system (KC+HC group only). The results indicate that LPS-induced downregulation of CYP1A2 gene expression was prevented by inhibition of TNF-· and IL-1ß (Fig. 4) .
Results

Alterations in the expression of CYP1A2, AhR, Arnt, and HSP90 and the release of TNF-· and IL-1ß in a Kupffer cell (KC)-hepatocyte (HC) coculture system. As shown in
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, AhR, and Arnt in primary hepatocyte culture. Hepatocytes were isolated from normal rats and cultured with or without TNF-· (0.02-2 ng/ml) or IL-1ß (0.02-2 ng/ml) for 48 h. CYP1A2, AhR and Arnt gene expression was determined using RT-PCR technique. The results indicate that incubation of hepatocytes with physiologically relevant amounts of TNF-· concentrationdependently decreased the gene expression of CYP1A2 and AhR ( Fig. 5A and B) without an affect of Arnt expression (Fig. 5C) . Similarly, incubation of hepatocytes with IL-1ß for 48 h reduced CYP1A2 and AhR expression ( Fig. 6A and B) , but not Arnt expression (Fig. 6C) .
Effects of curcumin administration on hepatic TNF-· and IL-1ß expression in sepsis.
As shown in Fig. 7A and B, hepatic levels of TNF-· and IL-1ß increased significantly at 20 h after CLP. Curcumin treatment markedly attenuated TNF-· and IL-1ß levels in the liver.
Effects of curcumin administration on hepatic CYP1A2, AhR expression in sepsis.
The gene and protein expression of CYP1A2 was decreased significantly 20 h after CLP, and curcumin treatment significantly improved their expression (Fig. 8A and B) . Likewise, reduced AhR gene and protein expression was also prevented after curcumin treatment ( Fig. 9A and B) .
Discussion
Expression of hepatic CYP can be affected genetically or environmentally. Environmental factors known to alter CYP isoforms include medications (e.g. barbiturates, anticonvulsants, rifampin), food (cruciferous vegetables), social habits (alcohol consumption, cigarette smoking), development, and disease conditions (diabetes, inflammation, and infection) (17) . Mediators involved in inflammation and sepsis can alter the drug metabolizing capabilities of hepatic CYPs (18-21) Proinflammatory cytokines play an important role in the regulation of CYP expression (5, 6) . When stimulated with TNF-·, IL-1ß, IFN-Á or IL-6, the expression of various CYP isoforms in cultured cells is downregulated (22) (23) (24) (25) (26) . There is a decrease in CYP isoforms in animal models of endotoxemia and in cultured hepatocytes stimulated by endotoxin (18, (27) (28) (29) (30) (31) (32) . However, very little work has been performed with hepatic CYP in animal models of sepsis aside from measuring mixed function oxidase (33) and comparing CYP3A expression in sepsis with endotoxic shock (34) . In this regard, our recent studies have shown that rat hepatic CYP1A2 mRNA was significantly downregulated at 10-20 h and its protein expression decreased at 20 h after CLP (2) . The observation that hepatic CYP1A2 gene expression decreased when hepatic perfusion increased at the early stage of sepsis (i.e. 10 h after CLP) (35) which indicates that other factors may participate in the suppression of hepatic CYP function in sepsis. The fact that plasma levels of endotoxin and proinflammatory cytokines such as TNF-· and IL-1ß increase very early after the onset of sepsis implies the possible role of LPS, TNF-· and IL-1ß on the suppression of CYP1A2 expression under such conditions. Using a KC and HC coculture system, our present study indicates that LPS did not suppress CYP1A2 expression in HC alone or HC/KC coculture with transwells. In the presence of direct cell-to-cell contact between HC and KC, however, LPS significantly downregulated CYP1A2 expression. Moreover, proinflammatory cytokine levels especially TNF-· in the supernatants of coculture without transwells were much higher than any other groups. TNF-· and IL-1ß alone also inhibited CYP1A2 gene expression, but additional time of stimulation was needed (24 h vs. 48 h). Anti-TNF-· and anti-IL-1ß antibodies attenuated the down-regulatory effect of LPS on CYP1A2 gene expression in HC and KC coculture with direct cell-to-cell contact. These results, taken together, indicate that proinflammatory cytokines released from KC, but not direct effects of LPS, play an important role in downregulating hepatic CYP1A2 expression in sepsis.
Nuclear receptors represent a superfamily of ligandmodulated transcription factors that mediate responses to steroids, retinoids, thyroid hormones, and various xenobiotics (36) . These receptors play a key role in development, cell differentiation, and organ physiology (37) . Unlike watersoluble hormones, steroid hormones can enter the cell by simple or facilitated diffusion and transduce their signals to the genome via intracellular receptors (38) . After binding to its receptor, the hormone-receptor complex moves from the cytoplasm to the nucleus, undergoing allosteric changes that enable the complex to bind to high affinity sites in the chromatin and modulate gene transcription (39) . More than 70 distinct members of the nuclear receptor superfamily have been identified (40) . Studies have shown that the transcription of CYP1A2 gene is mediated through the aryl hydrocarbon receptor (AhR) signaling pathway (11) (12) (13) . This is further supported by the finding that the human hepatoma cell line SK-Hep-1, which expresses defective AhR, is associated with the lack of CYP1A2 expression (41) . In the absence of stimulation, AhR exists as a non-DNA-binding, ~300 kDa heteromeric complex, associated with the molecular chaperone heat shock protein 90 (HSP90) in a 1:2 ratio in the cytosol (42) . Upon stimulation, AhR-HSP90 complex enters the nucleus and subsequently dissociates, enabling AhR to be phosphorylated by tyrosine kinase. Activated AhR then forms a heterodimer complex with its nuclear translocator (AhR nuclear translocator, Arnt) (43) . Within the nucleus, the AhR-Arnt complex recognizes and binds to the specific regulatory sequences known as the dioxin responsive element (DRE) at the promoter region, and initiates the transcription of the CYP1A2 gene (44, 45 ). HSP90 appears to be critical for folding of a ligandbinding conformation in AhR and for the ligand's inducibility (46, 47) . In this study, we found that the inhibition of CYP1A2 expression is associated with reduced levels of AhR/Arnt under both in vitro and in vivo conditions. Therefore, the inhibition of AhR/Arnt expression may be the underlying mechanism for downregulation of CYP1A2.
Curcumin is the major yellow pigment extracted from turmeric, a commonly used spice derived from the rhizome of the herb Curcuma longa. In the Indian subcontinent and Southeast Asia, turmeric has traditionally been used as a treatment for inflammation and skin wounds. Clinical activity of curcumin has yet to be confirmed; however, curcumin has known anti-inflammatory properties in preclinical animal models (48) . Curcumin is cytoprotective, and suppresses the hepatic microvascular inflammatory response to endotoxin as demonstrated by its inhibitory effects on KC activation, neutrophil adhesion, and endothelial cell swelling (49, 50) . In animal models, curcumin prevents ethanol-induced liver injury as well as ethanol and nonethanol experimental pancreatitis (51, 52) . Pre-treatment with curcumin attenuates hemorrhageinduced increases in proinflammatory cytokines and improves organ function under such conditions (53) . Our recent study also demonstrates that curcumin inhibits endotoxin-induced production of TNF-· from macrophages, as well as reduces circulating levels of TNF-· and attenuates organ injury in a CLP model of sepsis (54) . In this study, we found that significantly elevated hepatic levels of TNF-· and IL-1ß after CLP were reduced by curcumin treatment. This reduction in TNF-· and IL-1ß is associated with increased expression of AhR and CYP1A2 in the liver. Therefore, the restoration of hepatic CYP1A2 expression by curcumin treatment in septic animals is mediated through downregulation of proinflammatory cytokines involving an AhR/Arnt dependent pathway. Since the CYP enzyme system is essential in inflammation, and its inhibition leads to exacerbated proinflammatory responses and tissue injury, the beneficial effect of curcumin in sepsis is at least partially mediated by the restoration of hepatic CYP function. In summary, proinflammatory cytokines released from KC, but not direct effects of LPS, play an important role in downregulating hepatic CYP1A2 expression in sepsis. The reduction of AhR/Arnt expression may be the underlying mechanism for such downregulation. Inhibition of proinflammatory cytokines by curcumin may provide a novel therapeutic approach for the modulation of the hepatic CYP enzyme system under such conditions.
